Evidence map›Paper›PMID 36092270›Full record

ArticleIEEE transactions on radiation and plasma medical sciences2022

Development of Ultra-High Dose-Rate (FLASH) Particle Therapy.

Michele M Kim, Arash Darafsheh, Jan Schuemann, Ivana Dokic, Olle Lundh, Tianyu Zhao, José Ramos-Méndez, Lei Dong, Kristoffer Petersson

Abstract read
In one paragraph

Article in IEEE transactions on radiation and plasma medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michele M KimDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Arash DarafshehDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Jan SchuemannDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Ivana DokicClinical Cooperation Unit Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital (UKHD) and German Cancer Research Center (DKFZ), Im Neuenheimer Feld 460, Heidelberg, Germany.
Olle LundhDepartment of Physics, Lund University, Lund, Sweden.
Tianyu ZhaoDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
José Ramos-MéndezDepartment of Radiation Oncology, University of California San Francisco, San Francisco, California, USA.
Lei DongDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kristoffer PeterssonDepartment of Oncology, The Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.

Funding

TOPAS - nBio, a Monte Carlo tool for radiation biology researchR01CA187003 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SCHUEMANN, JAN PATRICK OSCAR · 2015 to 2024
$4.8M
Dose-Rate Variations for Patient Treatments in Flash and conventional radiation therapyR21CA252562 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SCHUEMANN, JAN PATRICK OSCAR · 2021 to 2022
$416k
Cancer Research UK 28736Medical Research Council MC_UU_00001/9NCI NIH HHS R01 CA187003NCI NIH HHS R21 CA252562
6 · The paper itself

Abstract

Research efforts in FLASH radiotherapy have increased at an accelerated pace recently. FLASH radiotherapy involves ultra-high dose rates and has shown to reduce toxicity to normal tissue while maintaining tumor response in pre-clinical studies when compared to conventional dose rate radiotherapy. The goal of this review is to summarize the studies performed to-date with proton, electron, and heavy ion FLASH radiotherapy, with particular emphasis on the physical aspects of each study and the advantages and disadvantages of each modality. Beam delivery parameters, experimental set-up, and the dosimetry tools used are described for each FLASH modality. In addition, modeling efforts and treatment planning for FLASH radiotherapy is discussed along with potential drawbacks when translated into the clinical setting. The final section concludes with further questions that have yet to be answered before safe clinical implementation of FLASH radiotherapy.

Indexed as

electron radiationFLASH effect modelingFLASH radiotherapyheavy-ion radiationproton radiation

Identifiers

PMID36092270
PMCPMC9457346

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.